Ivax Corporation

Legal manoeuvre delays launch of generic cancer drug

A legal manoeuvre by Bristol-Myers Squibb on 15/8 is likely to delay the launch of a less expensive, generic form of Taxol, the world's top selling cancer drug. A legal manoeuvre by Bristol-Myers Squibb on 15/8 is likely to delay the launch of a less expensive, generic form of Taxol, the world's top selling cancer drug.